Chargement en cours...
18F PET with flutemetamol for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI)
BACKGROUND: (18)F‐flutemetamol uptake by brain tissue, measured by positron emission tomography (PET), is accepted by regulatory agencies like the Food and Drug Administration (FDA) and the European Medicine Agencies (EMA) for assessing amyloid load in people with dementia. Its added value is mainly...
Enregistré dans:
| Publié dans: | Cochrane Database Syst Rev |
|---|---|
| Auteurs principaux: | , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
John Wiley & Sons, Ltd
2017
|
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6486287/ https://ncbi.nlm.nih.gov/pubmed/29164602 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD012884 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|